Press Releases July 23, 2026 08:30 AM

Lantheus to Host Second Quarter 2026 Earnings Conference Call and Webcast on August 6, 2026, at 8:00 a.m. Eastern Time

Lantheus Holdings schedules Q2 2026 earnings call and webcast on August 6, 2026.

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
LNTH

Lantheus Holdings, Inc., a leading radiopharmaceutical company headquartered in Massachusetts, announced it will hold its second quarter 2026 earnings conference call and webcast on August 6, 2026. The event will cover financial results and business updates, with access via online registration and replay availability.

Lantheus to Host Second Quarter 2026 Earnings Conference Call and Webcast on August 6, 2026, at 8:00 a.m. Eastern Time
LNTH
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • The conference call and webcast are scheduled for August 6, 2026, at 8:00 a.m. Eastern Time to discuss Q2 financial results and business updates.
  • Lantheus is a well-established radiopharmaceutical company with a global presence including offices in the US, Canada, and Europe.
  • The earnings call offers investors timely insight into company performance affecting the healthcare and pharmaceutical sectors.

BEDFORD, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, August 6, 2026, to discuss its financial results and provide a business update for the second quarter of 2026.

To access the conference call or webcast, participants should register online at https://investor.lantheus.com/news-events/calendar-of-events. To avoid delays, we encourage participants to register fifteen minutes ahead of the scheduled start time.

A replay will be available approximately two hours after completion of the webcast and will be archived on the same web page for at least 30 days.

About Lantheus
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada, Germany, Sweden, Switzerland and the United Kingdom, Lantheus has been providing radiopharmaceutical solutions for 70 years. For more information, visit www.lantheus.com.

Contacts:

Mark Kinarney
Vice President, Investor Relations
978-671-8842
[email protected]

Melissa Downs
Executive Director, External Communications
646-975-2533
[email protected]


Risks

  • Financial results may underperform expectations impacting investor confidence and the stock price.
  • Market conditions or regulatory changes in the radiopharmaceutical or healthcare sectors could affect business outlook.
  • Uncertainties related to global operations, including impacts from international markets, may influence company performance.

More from Press Releases

Jyong Biotech Highlights Multi-Billion Dollar Global BPH Market Opportunity and Reaffirms Strategic Focus on Global Licensing Partnerships Jul 23, 2026 GBank Financial Holdings Inc. is Pleased To Share the Press Release of Bankroll LLC [BVNKROLL] Jul 23, 2026 EZCORP to Release Third Quarter Fiscal 2026 Results After Market Close on Wednesday, August 5, 2026 Jul 23, 2026 Silvercrest Asset Management Rebrands International and Global Value Platform as the Silvercrest Focused Value Platform Jul 23, 2026 CBIZ Launches CBIZ Retirement Advantage PEP (Pooled Employer Plan) to Help Middle-Market Businesses Attract, Retain and Reward Talent by Simplifying Retirement Plan Administration and Enhancing Employee Benefits Jul 23, 2026